Provided by Tiger Fintech (Singapore) Pte. Ltd.

RxSIGHT, INC.

16.26
+0.05000.31%
Post-market: 16.300.0350+0.22%18:59 EDT
Volume:2.11M
Turnover:33.49M
Market Cap:658.38M
PE:-23.02
High:16.56
Open:15.17
Low:15.01
Close:16.21
Loading ...

Company Profile

Company Name:
RxSIGHT, INC.
Exchange:
NASDAQ
Establishment Date:
1997
Employees:
498
Office Location:
100 Columbia,Aliso Viejo,California,United States
Zip Code:
92656
Fax:
- -
Introduction:
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Directors

Name
Position
Ron Kurtz
President, Chief Executive Officer & Director
J. Andy Corley
Chair of the Board
Julie B. Andrews
Director
Juliet Tammenoms Bakker
Director
Robert J. Palmisano
Director
Robert Warner
Director
William J. Link
Director

Shareholders

Name
Position
Ron Kurtz
President, Chief Executive Officer & Director
Ilya Goldshleger
Chief Operating Officer
Shelley Thunen
Chief Financial Officer
Eric Weinberg
Chief Commercial Officer